Pierre DENYS

head of the department

France

Research Interests

Explore related searches

Professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Pierre Denys is the head of the Department at Raymond Poincaré University Hospital in France. His research focuses on neuro-urology, specifically the use of botulinum toxin for treating various conditions such as neurogenic detrusor overactivity and erectile dysfunction. He has published several articles addressing real-world applications and safety of botulinum toxin injections, as well as best practices in intermittent catheterization.

Articles (11)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (5)

Xavier Gamé

FRANCE

View details

Stephane Lezmi

UNITED STATES

View details

Karl-Erik Andersson

Professor

Wake Forest University

UNITED STATES

View details

emmanuel chartier-kastler

Professeur des Universités

Sorbonne Université

FRANCE

View details

Claire Hentzen

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Pierre DENYS

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Concomitant Botulinum Toxin Injections for Neurogenic Detrusor Overactivity and Spasticity—A Retrospective Analysis of Practice and Safety

Real-World Use of Intradetrusor Botulinum Toxin Injections: A Population-Based Study from France

The International Continence Society (ICS) survey on intermittent catheterization and global practices with regard to the reuse of catheters

Safety and Effectiveness of Repeated Botulinum Toxin A Intracavernosal Injections in Men with Erectile Dysfunction Unresponsive to Approved Pharmacological Treatments: Real-World Observational Data

AbobotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity regardless of spinal cord injury or multiple sclerosis etiology: Pooled analysis of two phase III randomized studies (CONTENT1 and CONTENT2)

BoNT/A1 Secondary Failure for the Treatment of Neurogenic Detrusor Overactivity: An Ex Vivo Functional Study

Acute Intravesical Capsaicin for the Study of TRPV1 in the Lower Urinary Tract: Clinical Relevance and Potential for Innovation

Effectiveness and Safety of Intracavernosal IncobotulinumtoxinA (Xeomin®) 100 U as an Add-on Therapy to Standard Pharmacological Treatment for Difficult-to-Treat Erectile Dysfunction: A Case Series

Efficacy and Safety of AbobotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Incontinence Performing Regular Clean Intermittent Catheterization: Pooled Results from Two Phase 3 Randomized Studies (CONTENT1 and CONTENT2).

Predictive factors of diagnostic and therapeutic divergence in a nationwide cohort of patients seeking second medical opinion.

Collaborators (5)

Xavier Gamé

Stephane Lezmi

Karl-Erik Andersson

emmanuel chartier-kastler

Claire Hentzen

Make your next move.